OpenEvidence, a medical AI and clinical decision support tool for U.S. clinicians, is teaming up with NewYork-Presbyterian and its affiliated medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, to deploy OpenEvidence across all hospitals and care sites throughout the Greater New York region. This enterprise-scale collaboration will place trusted, evidence-based clinical AI in the hands of providers serving millions of patients across New York City’s five boroughs and Westchester.
OpenEvidence will be available to clinical staff at NewYork-Presbyterian, Columbia and Weill Cornell Medicine, allowing them to ask complex medical questions in conversational language and receive answers that are grounded in research and guidelines, with evidence interpreted through the lens that matters most: the individual patient.
“Every patient is unique, and their care should reflect that,” said Chif Umejei, Chief Information Officer at NewYork-Presbyterian. “By making OpenEvidence available across our systems, clinicians can use AI to seamlessly access and analyze medical research in real time and use that information to deliver informed and compassionate care to the communities we serve.”
“The campuses of NewYork-Presbyterian, Columbia and Weill Cornell Medicine span the full geographic and demographic range of Greater New York, serving one of the most linguistically, culturally, and clinically complex patient populations in the world,” said Travis Zack, MD, PhD, Chief Medical Officer of OpenEvidence. “Deploying OpenEvidence across the care teams of a leading academic healthcare system and two premier medical schools provides every clinician, regardless of setting, equal access to the best available evidence for every patient they see.”
OpenEvidence is the fastest-growing and most widely-used clinical decision support tool and medical search engine among U.S. clinicians. OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to make high-stakes clinical decisions at the point of care that are sourced, cited, and grounded in peer-reviewed medical literature.
Based in Miami, OpenEvidence is backed by investors including Google, Andreessen Horowitz and Sequoia.
